Carisoprodol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00395 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 37 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | alcohol withdrawal delirium | KG + DL |
| 3 | visual epilepsy | KG + DL |
| 4 | pharyngitis | KG + DL |
| 5 | nasal cavity disease | KG + DL |
| 6 | startle epilepsy | KG + DL |
| 7 | orgasm-induced seizures | KG + DL |
| 8 | thinking seizures | KG + DL |
| 9 | micturation-induced seizures | KG + DL |
| 10 | audiogenic seizures | KG + DL |
| 11 | eating seizures | KG + DL |
| 12 | neuralgia | KG + DL |
| 13 | acute laryngopharyngitis | KG + DL |
| 14 | antidepressant type abuse | KG + DL |
| 15 | barbiturate abuse | KG + DL |
| 16 | hallucinogen abuse | KG + DL |
| 17 | irritable bowel syndrome | KG + DL |
| 18 | reading seizures | KG + DL |
| 19 | methemoglobinemia | KG + DL |
| 20 | cauda equina syndrome | KG + DL |
| 21 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 22 | common cold | KG + DL |
| 23 | phencyclidine abuse | KG + DL |
| 24 | rhinitis | KG + DL |
| 25 | restless legs syndrome | KG + DL |
| 26 | alcohol withdrawal | KG + DL |
| 27 | conjunctivitis | KG + DL |
| 28 | glossodynia | KG + DL |
| 29 | coccygodynia | KG + DL |
| 30 | status epilepticus | KG + DL |
| 31 | myofascial pain syndrome | KG + DL |
| 32 | alcohol-related disorders | KG + DL |
| 33 | anxiety | KG + DL |
| 34 | manic bipolar affective disorder | KG + DL |
| 35 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 36 | cluster headache syndrome | KG + DL |
| 37 | headache disorder | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.